Skip to main content

As the situation in Ukraine evolves, businesses should be mindful of potential risks to their people, assets, operations, or supply chains in the region and globally. Marsh, as part of the Marsh McLennan family of companies, has created a page with information, tools, and resources related to the Russia-Ukraine conflict. Please visit the page for the latest information.

June 14, 2024

CNBC quotes Kate Moher

Companies are increasing access to new weight-loss drugs for employees, but the size of employer may make a big difference in early access.

Small businesses and their workers are often stuck between a rock and a hard place. Covering these drugs is harder for smaller employers, many of whom rely on off-the-shelf plans offered by their insurance carriers. While there are plans that cover GLP-1 drugs, the cost can be prohibitive for many small businesses. 

“The market is changing quickly. Last year, an insurance carrier asked about covering weight-loss drugs may have said no, but it’s worth asking the carrier again because they may have been forced to make changes to their offerings for competitive reasons,” said Kate Moher, president of national employee health and benefits for Marsh McLennan Agency.

Read the full article to learn about how weight-loss drugs affect today’s health insurance market.